Mirae Asset Global Investments’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Mirae Asset Global Investments’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-7,818	Closed	-$1.38M	–	1789
2021 Q3	$1.38M	Buy	7,818 +692	+10%	+$111K	﹤0.01%	1206
2021 Q2	$1.15M	Buy	7,126 +816	+13%	+$131K	﹤0.01%	1206
2021 Q1	$1.08M	Buy	6,310 +459	+8%	+$90.9K	﹤0.01%	1109
2020 Q4	$1.28M	Buy	5,851 +1,624	+38%	+$351K	﹤0.01%	1067
2020 Q3	$702K	Sell	4,227 -2,322	-35%	-$318K	﹤0.01%	1086
2020 Q2	$748K	Buy	6,549 +839	+15%	+$81.4K	﹤0.01%	999
2020 Q1	$439K	Buy	5,710 +1,211	+27%	+$109K	﹤0.01%	1065
2019 Q4	$580K	Buy	4,499 +163	+4%	+$15.7K	﹤0.01%	1157
2019 Q3	$338K	Buy	+4,336	New	+$407K	﹤0.01%	1282

Other funds holding MRTX

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Mirae Asset Global Investments's MRTX Position: Q4 2021 in Review

Mirae Asset Global Investments sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q4 2021, closing a stake of 7,818 shares — an estimated $1.38M sold.

Mirae Asset Global Investments first reported a position in MRTX in Q3 2019 and held it in 9 quarters. The position peaked at $1.38M in Q3 2021. 260 funds tracked by Wall St. Rank hold MRTX as of Q4 2021.

Mirae Asset Global Investments reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Mirae Asset Global Investments sold 7,818 Mirati Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $1.38M.
Mirae Asset Global Investments first reported a position in Mirati Therapeutics, Inc. Common Stock in Q3 2019 and held it in 9 quarters.
Mirae Asset Global Investments's Mirati Therapeutics, Inc. Common Stock position peaked at $1.38M in Q3 2021.
260 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q4 2021.

Based on Mirae Asset Global Investments's 13F filing for Q4 2021, filed 8 Feb 2022.